#ICYMI: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and #CART Cell Therapy by Tamari, Shah et al. https://t.co/8pLa5geHWj #COVID19 https://t.co/9iHrwdiySV
RT @BCD_AACR: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy. htt…
RT @BCD_AACR: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy. htt…
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy. https://t.co/LFTp8ttGAt #AACRCOVIDReport https://t.co/EWrxlhUklu
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy. https://t.co/g9dKo9ALRn #AACRCOVIDReport
RT @DrMiguelPerales: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Thera…
RT @DrMiguelPerales: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Thera…
RT @DrMiguelPerales: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Thera…
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy @BCD_AACR by @tamari_roni @GunjanLShah @sloan_kettering #COVID19 #NationalWomenPhysiciansDay 6/n https://t.co/5ydf4dbADJ
RT @DrMiguelPerales: Paper is online in @BCD_AACR #ASH21 #Cocvid19 #CovidVaccines https://t.co/tSG0Xmbf2W
RT @DrMiguelPerales: Paper is online in @BCD_AACR #ASH21 #Cocvid19 #CovidVaccines https://t.co/tSG0Xmbf2W
Paper is online in @BCD_AACR #ASH21 #Cocvid19 #CovidVaccines https://t.co/tSG0Xmbf2W
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy https://t.co/JnZlmnpGZg
Could be of interest to the MS world as well (HSCT): At 3 months after vaccination, 188 patients (87%) had positive spike Ab levels and 139 (77%) had positive neutralization activity
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
Very cool study. Congratulations @GunjanLShah @DrMiguelPerales @ipolitikos @GenPapaMD #VaccinesWork (also in CAR-T and HCT patients)
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy #lymphoma #lymsm https://t.co/HqhBb6rVnW
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
RT @CARTTherapy: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy h…
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy https://t.co/0UO2IPJJnZ #COVID19 #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @ASTCT
#ICYMI: Among 217 transplant therapy recipients, response to vaccination correlated with degree of immune recovery after transplantation. Tracking immune recovery offers cue to when patients regain ability to respond to vaccines. https://t.co/kitgDSzXqc ht
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
Important set of considerations. The covid pandemic is not over especially for those with heme malignancies or baseline immunosuppression. We could use some data on prophylaxis of Mab cocktails in these high risk patients
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
RT @SantoshVardhana: This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in…
This is exactly right. We have actually published on this: patients with hematologic malignancies are compromised in multiple aspects when combatting COVID. First, many treatments for multiple myeloma suppress antibody responses to vaccination: https://t
RT @DrMvandenBrink: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therap…
RT @AkshaySharmaMD: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therap…
RT @DrMvandenBrink: Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therap…
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy | Blood Cancer Discovery #BMTsm #COVID19 #Vaccines https://t.co/wsbWtVpN8W
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy https://t.co/2aivVsksu2
RT @_TanyaBondar_: And thanks to @DavidKnorrMDPhD @tamari_roni @sloan_kettering for contributing data for the analysis ahead of publication…
And thanks to @DavidKnorrMDPhD @tamari_roni @sloan_kettering for contributing data for the analysis ahead of publication. These findings had a major impact on overall conclusions and policy recommendations. https://t.co/R8C88hiTLA https://t.co/K16mKQNoyP
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
RT @CyclingDoctor: More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 y…
More from MSKCC--COVID vaccine response (Ig and neutralizing) after SCT poor especially after CAR-T. Best in allos >3 yrs #bmtsm #mmsm #leusm #lymsm @COVID19nCCC @mtmdphd @rubinstein_md https://t.co/Uy9B4Kkuhz https://t.co/9XXgLJaUgJ
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
RT @BCD_AACR: @sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination corre…
@sloan_kettering Among 217 transplant therapy recipients, including 7 treated with CAR T cells, response to vaccination correlated with the degree of immune recovery after transplantation. https://t.co/KBF4bNBR6r https://t.co/0A8eN9KD7v